The company has continued its momentum into 2025, gaining 82% this year and nearly 60% in the last week. Sam Altman first got involved with Oklo in 2014, when he was still the president of startup ...
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
Some results have been hidden because they may be inaccessible to you